La Roche-Posay Cicaplast B5 Spray provides targeted, touch-free relief for uncomfortable, damaged, or irritated skin. This concentrated formula delivers a lightweight, invisible mist that immediately soothes discomfort while accelerating natural skin barrier repair. Designed with wide diffusion for hard-to-reach or painful-to-touch areas, it offers a quick-absorbing finish that respects the skin microbiome without leaving a sticky or drying residue.

Key Features

• Touch-Free Application: Features a wide diffusion spray pattern to soothe hard-to-reach or painful skin conditions without physical contact.
• Barrier Repair Support: Accelerates epidermal repair, supports moisture barrier restoration, and respects the skin microbiome.
• Hygienic Protection: Contains antibacterial action to help protect broken skin from infection and create an optimal environment for healing to reduce long-term scarring.
• Family Suitable: Suitable for use on the face and body of adults, children, and babies from 3 months of age across various skin conditions including burns, nappy rash, chickenpox, and post-procedure skin.
• Safety Tested: Tested under dermatological, ophthalmological, and paediatric control for high tolerance on sensitive or fragile skin.
• Minimalist Formula: Hypoallergenic, fragrance-free, alcohol-free, and formulated without drying agents.
• Lightweight Finish: Delivers an invisible, non-drying spray that absorbs quickly with a non-shiny, non-sticky finish.
• Dermatologist Recommended: Developed by Australia's number one dermatologist recommended skincare brand [1].

Hero Ingredients

• Panthenol 5% (Vitamin B5): Renowned for its ultra-nourishing, skin-soothing, and skin barrier benefits.
• Madecassoside: Provides anti-inflammatory and anti-ageing benefits while visibly reducing redness and boosting skin hydration.
• Glycerin: A humectant that helps hydrate skin by absorbing moisture from the surrounding environment.

[1] AplusA Healthcare Market Research, Dermatologist barometer survey, Australian dermocosmetic market, January to May 2024.